ING Groep NV bought a new position in Encompass Health Corp (AMEX:EHC) in the second quarter, Holdings Channel reports. The firm bought 10,404 shares of the company’s stock, valued at approximately $705,000.
Other institutional investors also recently made changes to their positions in the company. Hancock Holding Co. purchased a new position in shares of Encompass Health in the 1st quarter worth approximately $8,590,000. Smith Asset Management Group LP boosted its holdings in Encompass Health by 3.7% during the 2nd quarter. Smith Asset Management Group LP now owns 49,313 shares of the company’s stock valued at $3,339,000 after acquiring an additional 1,740 shares during the period. Principal Financial Group Inc. purchased a new position in Encompass Health during the 1st quarter valued at $76,632,000. Ardevora Asset Management LLP purchased a new position in Encompass Health during the 2nd quarter valued at $35,810,000. Finally, Marietta Investment Partners LLC purchased a new position in Encompass Health during the 2nd quarter valued at $847,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
In other Encompass Health news, insider Andrew L. Price sold 9,457 shares of the company’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $80.04, for a total value of $756,938.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Cheryl B. Levy sold 28,955 shares of the company’s stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $78.00, for a total value of $2,258,490.00. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
A number of research firms recently issued reports on EHC. Mizuho restated a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a report on Thursday, July 26th. Zacks Investment Research upgraded Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 price objective for the company in a report on Friday, July 27th. Piper Jaffray Companies upgraded Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. Credit Suisse Group boosted their price objective on Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, July 26th. Finally, SunTrust Banks restated a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a report on Friday, July 20th. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $71.10.
EHC opened at $57.67 on Thursday. Encompass Health Corp has a 52-week low of $40.86 and a 52-week high of $59.29. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.
Encompass Health (AMEX:EHC) last issued its earnings results on Wednesday, July 25th. The company reported $0.99 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.83 by $0.16. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.03 billion. The firm’s quarterly revenue was up 10.5% compared to the same quarter last year. equities analysts expect that Encompass Health Corp will post 2.72 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Shareholders of record on Monday, October 1st will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 1.87%. This is a boost from Encompass Health’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, September 28th.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Featured Story: Google Finance Portfolio Workaround
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.